|Pam3CSK4 Rhodamine||Unit size||Cat. code||Docs||Qty||Price|
Rhodamine-labeled TLR2 Agonist
Rhodamine-labeled synthetic triacylated lipoprotein
Pam3CSK4 is a synthetic triacylated lipopeptide (LP) that mimics the acylated amino terminus of bacterial LPs. Pam3CSK4 is a potent activator of the proinflammatory transcription factor NF-κB. Activation is mediated by the interaction between TLR2 and TLR1 which recognize LPs with three fatty acids, a structural characteristic of bacterial LPs.
Specificity: TLR 1/2 agonist
Working concentration: 1 ng - 300 ng/ml
Molecular formula: C118H199N14O19S, 2 TFA
Molecular weight: 2150
Endotoxin level: <0.001 EU/μg
Spectral properties of carboxy tetramethyl rhodamine
Excitation λ max: 549 nm
Emission λ max: 566 nm
• 50 μg Pam3CSK4 Rhodamine x 2 TFA
• 1.5 ml endotoxin-free water
Pam3CSK4 Rhodamine is provided lyophilized and shipped at room temperature. Store at 4°C. Protect from light. Upon resuspension, prepare aliquots of Pam3CSK4 Rhodamine and store at 4°C for short term storage or -20°C for long storage. Resuspended product is stable 1 month at 4°C and 6 months at -20°C when properly stored.Back to the top
Bacterial lipoproteins are a family of proinflammatory cell wall components found in both Gram positive and Gram negative bacteria. The stimulatory activity of bacterial lipoproteins resides in their acylated amino terminus. Pam3CSK4 is a synthetic tripalmitoylated lipopeptide that mimicks the acylated amino terminus of bacterial lipoproteins. Pam3CysSerLys4 (Pam3CSK4) is a potent activator of the proinflammatory transcription factor NF-κB . Recognition of Pam3CSK4 is mediated by TLR2 which cooperates with TLR1 through their cytoplasmic domain to induce the signaling cascade leading to the activation of NF-κB .
1. Aliprantis AO et al., 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science.285(5428):736-9.
2. Ozinsky A. et al., 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. PNAS. 97(25):13766-71.